NASDAQ: TENXTenax Therapeutics Inc Stock Ownership - Who owns Tenax Therapeutics?
Insider buying vs selling
Have Tenax Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Declan Doogan | Director | 2026-09-16 | 53,000 | $1.92 | $101.76kBuy |
| Christopher Thomas Giordano | CEO | 2026-09-15 | 4,850 | $1.82 | $8.84kBuy |
| Christopher Thomas Giordano | CEO | 2026-09-11 | 6,000 | $1.88 | $11.25kBuy |
| Thomas R. Staab Ii | CFO | 2026-09-11 | 5,675 | $1.94 | $10.98kBuy |
| Adar1 Capital Management LLC | 10% Owner | 2026-09-03 | 900,000 | $1.78 | $1.60MBuy |
| Adar1 Capital Management LLC | 10% Owner | 2026-09-02 | 187,704 | $1.80 | $337.49kBuy |
| Adar1 Capital Management LLC | 10% Owner | 2026-09-01 | 179,058 | $1.80 | $321.59kBuy |
| Adar1 Capital Management LLC | 10% Owner | 2026-08-31 | 403,571 | $1.79 | $722.39kBuy |
| Adar1 Capital Management LLC | 10% Owner | 2026-08-24 | 107,374 | $1.75 | $188.33kBuy |
| Adar1 Capital Management LLC | 10% Owner | 2026-08-21 | 716,369 | $1.77 | $1.27MBuy |
TENX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when TENX insiders and whales buy or sell their stock.
TENX Shareholders
What type of owners hold Tenax Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Adar1 Capital Management LLC | 17.43% | 6,524,151 | $11.81M | Insider |
| Armistice Capital LLC | 16.11% | 6,027,985 | $10.91M | Insider |
| John P. Kelley | 3.43% | 1,282,932 | $2.32M | Insider |
| Dellora Investments LP | 0.94% | 351,071 | $635.44k | Insider |
| Christian J. Stern | 0.39% | 147,607 | $267.17k | Insider |
| Declan Doogan | 0.15% | 55,274 | $100.05k | Insider |
| James P. Mitchum | 0.12% | 45,000 | $81.45k | Insider |
| William A. Chatfield | 0.11% | 42,289 | $76.54k | Insider |
| Michael B. Jebsen | 0.09% | 34,680 | $62.77k | Insider |
| Christopher Thomas Giordano | 0.06% | 22,174 | $40.13k | Insider |
TENX vs Biotech Stocks
Tenax Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.